DEERFIELD, Ill. / Feb 18, 2025 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 1, 2025.
About Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
| Last Trade: | US$22.75 |
| Daily Change: | -0.15 -0.66 |
| Daily Volume: | 4,691,357 |
| Market Cap: | US$11.680B |
September 16, 2025 July 31, 2025 July 07, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
